Oncoinvent ASA
ONCIN.OLDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Radspherin | Phase 2 | Peritoneal Carcinomatosis | - | - |
Frequently asked questions
What is in Oncoinvent ASA's drug pipeline?→
CatalystAlert tracks 1 drug candidate in Oncoinvent ASA's (ONCIN.OL) pipeline across Phase 2. Its lead program is Radspherin (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Oncoinvent ASA's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Oncoinvent ASA (ONCIN.OL) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ONCIN.OL biotech catalysts?→
Add ONCIN.OL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Oncoinvent ASA's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.